Kathleen O'Sullivan, M.S., M.S.J., RAC, has extensive experience in regulatory affairs, holding leadership positions in prominent companies such as Bayer, PDI, BD, Barr Laboratories, and MediMedia USA. Currently serving as Director of Regulatory Strategy at Bayer, Kathleen has previously worked as Senior Director of Regulatory Affairs at PDI, Associate Director of Regulatory Affairs Integration Operations and Worldwide Director of Regulatory Affairs for Diabetes Care at BD, and Manager of Regulatory Operations at Barr Laboratories, among other roles. Kathleen holds a Master of Science in Jurisprudence focused on Pharmaceutical and Medical Device Law from Seton Hall University School of Law and a Bachelor of Science in Business Administration and Management from Dominican College of Blauvelt.
April, 2022 - present